Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Sera Prognostics, Inc. before investing.

In this article, we go over a few key elements for understanding Sera Prognostics, Inc.’s stock price such as:

• Sera Prognostics, Inc.’s current stock price and volume
• Why Sera Prognostics, Inc.’s stock price changed recently
• Upgrades and downgrades for SERA from analysts
• SERA’s stock price momentum as measured by its relative strength

About Sera Prognostics, Inc. (SERA)

Before we jump into Sera Prognostics, Inc.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Sera Prognostics, Inc., a women’s health company, discovers, develops, and commercializes blood-based biomarker tests, and predictive analytic products and services in the United States. The company develops the PreTRM test, a non-invasive blood test given to a pregnant woman, carrying a single fetus, during weeks 18 through 20 of gestation. It is also involved in the development of a pipeline of novel blood-based biomarker tests and predictive analytic products and services for pregnancy related conditions, such as time-to-birth, predictive analytics product, pregnancy risk prediction panel, preeclampsia, and fetal growth restriction. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.

Want to learn more about Sera Prognostics, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Sera Prognostics, Inc..

Sera Prognostics, Inc.’s Stock Price as of Market Close

As of September 04, 2026, 4:00 PM, CST, Sera Prognostics, Inc.’s stock price was $2.020.

Sera Prognostics, Inc. is up 2.02% from its previous closing price of $1.980.

During the last market session, Sera Prognostics, Inc.’s stock traded between $1.970 and $2.050. Currently, there are approximately 50.48 million shares outstanding for Sera Prognostics, Inc..

Sera Prognostics, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Sera Prognostics, Inc. Stock Price History

Sera Prognostics, Inc.’s (SERA) price is currently down 4.72% so far this month.

During the month of September, Sera Prognostics, Inc.’s stock price has reached a high of $2.180 and a low of $1.970.

Over the last year, Sera Prognostics, Inc. has hit prices as high as $3.950 and as low as $1.560. Year to date, Sera Prognostics, Inc.’s stock is down 31.53%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Sera Prognostics, Inc. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of September 04, 2026, there were 0 analysts who downgraded Sera Prognostics, Inc.’s stock and 1 analyst who upgraded over the last month.

Additionally, you'll want to evaluate Sera Prognostics, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Sera Prognostics, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Sera Prognostics, Inc. (SERA) by visiting AAII Stock Evaluator.

Relative Price Strength of Sera Prognostics, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of September 04, 2026, Sera Prognostics, Inc. has a weighted four-quarter relative price strength of -13.20%, which translates to a Momentum Score of 18 and is considered to be Very Weak.

Want to learn more about how Sera Prognostics, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Sera Prognostics, Inc. Stock Price: Bottom Line

As of September 4, 2026, Sera Prognostics, Inc.’s stock price is $2.020, which is up 2.02% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Sera Prognostics, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.